TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Integral Diagnostics Ltd. ( (AU:IDX) ) is now available.
Integral Diagnostics Ltd. announced the issuance of 677 performance rights under an employee incentive scheme. These unquoted securities are subject to transfer restrictions and are not listed on the ASX, indicating a strategic move to incentivize employees and align their interests with company performance.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, providing diagnostic imaging services. The company focuses on delivering high-quality radiology services across Australia and New Zealand, catering to a wide range of medical needs.
Average Trading Volume: 1,063,185
Technical Sentiment Signal: Buy
Current Market Cap: A$1.01B
For a thorough assessment of IDX stock, go to TipRanks’ Stock Analysis page.